Press Release: ORIG3N : Stratify Genomics and Orig3n sign commercial partnership
SAN DIEGO and BOSTON, Dec. 17, 2019 /PRNewswire/ -- Stratify Genomics, a pioneer in genetic cancer risk tests for the general population, today announced a commercial partnership with Orig3n, the leader in lifestyle genetic testing. The partnership will serve to empower individuals with...
Read full article »
ORIG3N develops treatments for rare genetically inherited diseases with a focus on heart, liver and neurodegenerative indications.
Read more